What do we learn from spheroid culture systems? Insights from tumorspheres derived from primary colon cancer tissue

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Qureshi Baig, Komal ^a   Ullmann, Pit ^a   Rodriguez, Fabien ^a   Frasquilho, Sónia ^b   Nazarov, Petr V ^c   Haan, Serge ^a   Letellier, Elisabeth ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b INTEGRATED BIOBANK OF LUXEMBOURG   (Luxembourg)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; FLUOROURACIL; LGR5 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; WNT PROTEIN; G PROTEIN COUPLED RECEPTOR; HOMEODOMAIN PROTEIN; LGR5 PROTEIN, HUMAN; NANOG PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CARCINOGENICITY; CDA ENE; CELL SELF-RENEWAL; COLON CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GST4A GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; RELAPSE; THERAPY RESISTANCE; TUMOR SPHEROID; ANIMAL; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; COLON TUMOR; CYTOLOGY; DNA MICROARRAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; MORTALITY; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; SURVIVAL ANALYSIS; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COLONIC NEOPLASMS; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, FLUORESCENCE; NANOG HOMEOBOX PROTEIN; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; SURVIVAL ANALYSIS; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84954350171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146052     Document Type: Article

References (75)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin. 2012; 62:10-29. doi: 10.3322/caac.20138 PMID: 22237781
2. Magee J a, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell [Internet]. Elsevier Inc.; 2012 [cited 2012 Nov 7]; 21:283-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22439924 doi: 10.1016/j.ccr.2012.03.003 PMID: 22439924
3. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell [Internet]. Elsevier Inc.; 2014; 14:275-91. Available from: http://dx.doi.org/10.1016/j.stem.2014.02.006 doi: 10.1016/j.stem.2014.02.006 PMID: 24607403
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003; 100:3983-8. PMID: 12629218
5. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003; 17:1253-70. PMID: 12756227
6. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005; 65:9328-37. PMID: 16230395
7. Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004; 432:396-401. PMID: 15549107
8. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer. 2007; 7:733-6. PMID: 17882276
9. Hemmati HD, Nakano I, Lazareff J a, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003; 100:15178-83. PMID: 14645703
10. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer. Cell Stem Cell. 2007; 1:313-23. doi: 10.1016/j.stem.2007.06.002 PMID: 18371365
11. Bender Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121:823-35. PMID: 15960971
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature [Internet]. 2007 [cited 2012 Oct 25]; 445:111-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17122771 PMID: 17122771
13. O'Brien C a, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature [Internet]. 2007 [cited 2012 Oct 25]; 445:106-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17122772 PMID: 17122772
14. Yang C, Jin K, Tong Y, Cho WC. Therapeutic potential of cancer stem cells. Med. Oncol. [Internet]. 2015 [cited 2015 May 21]; 32:619. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25920610 doi: 10.1007/s12032-015-0619-6 PMID: 25920610
15. Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. [Internet]. Elsevier Ltd; 2012 [cited 2012 Nov 2]; 13: e83-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22300863 doi: 10.1016/S1470-2045(11) 70257-1 PMID: 22300863
16. Chen K, Huang Y, Chen J. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol. Sin. [Internet]. 2013 [cited 2014 Aug 30]; 34:732-40. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3674516&tool=pmcentrez&rendertype= abstract doi: 10.1038/aps.2013.27 PMID: 23685952
17. Islam F, Gopalan V, Smith RA, Lam AK-Y. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in Cancer recurrence and cancer treatment. Exp. Cell Res. [Internet]. 2015 [cited 2015 May 12]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/25967525
18. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63:5821-8. PMID: 14522905
19. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell [Internet]. 2006 [cited 2015 May 26]; 9:391-403. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16697959 PMID: 16697959
20. Ponti D. Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties. Cancer Res. 2005; 65:5506-11. PMID: 15994920
21. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell [Internet]. 2007 [cited 2012 Mar 8]; 1:389-402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18371377 doi: 10.1016/j.stem.2007.08.001 PMID: 18371377
22. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. U. S. A. [Internet]. 2008; 105:13427-32. Available from: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=2533206&tool=pmcentrez&rendertype=abstract doi: 10.1073/pnas.0805706105 PMID: 18765800
23. Lee S-H, Hong JH, Park HK, Park JS, Kim B-K, Lee J-Y, et al. Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors. Cancer Lett. [Internet]. 2015 [cited 2015 Jul 21]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/26185002
24. Kondo J, Endo H, Okuyama H, Ishikawa O, Iishi H, Tsujii M, et al. Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. [Internet]. 2011 [cited 2012 Nov 8]; 108:6235-40. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3076886&tool=pmcentrez&rendertype=abstract doi: 10.1073/pnas.1015938108 PMID: 21444794
25. Weiswald L-B, Bellet D, Dangles-Marie V. Spherical Cancer Models in Tumor Biology. Neoplasia [Internet]. Neoplasia Press, Inc.; 2015; 17:1-15. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1476558614001948 doi: 10.1016/j.neo.2014.12.004 PMID: 25622895
26. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. [Internet]. 2010 [cited 2014 Jul 16]; 148:3-15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20097238 doi: 10.1016/j. jbiotec.2010.01.012 PMID: 20097238
27. Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. [Internet]. Nature Publishing Group; 2010 [cited 2012 Oct 25]; 12:468-76. Available from: http://www.nature.com/doifinder/10.1038/ncb2048 doi: 10.1038/ncb2048 PMID: 20418870
28. Cammareri P, Lombardo Y, Francipane MG, Bonventre S, Todaro M, Stassi G. Isolation and culture of colon cancer stem cells. Methods Cell Biol. [Internet]. 2008 [cited 2011 Dec 13]; 86:311-24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18442654 doi: 10.1016/S0091-679X(08)00014-9 PMID: 18442654
29. Collura A, Marisa L, Trojan D, Buhard O, Lagrange A, Saget A, et al. Extensive characterization of sphere models established from colorectal cancer cell lines. Cell. Mol. Life Sci. [Internet]. 2013 [cited 2013 Nov 11]; 70:729-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23007843 doi: 10.1007/s00018-012-1160-9 PMID: 23007843
30. Weiswald L-B, Richon S, Massonnet G, Guinebretière J-M, Vacher S, Laurendeau I, et al. A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation. Br. J. Cancer [Internet]. 2013 [cited 2015 Nov 18]; 108:1720-31. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3668460&tool=pmcentrez&rendertype=abstract doi: 10.1038/bjc.2013.132 PMID: 23538387
31. Muraro MG, Mele V, Daster S, Han J, Heberer M, Cesare Spagnoli G, et al. CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines. Stem Cells Transl. Med. 2012; 1:592-603. doi: 10.5966/sctm.2012-0003 PMID: 23197865
32. Wu H, Zhang H, Hu Y, Xia Q, Liu C, Li Y, et al. Sphere formation assay is not an effective method for cancer stem cell derivation and characterization from the Caco-2 colorectal cell line. Curr. Stem Cell Res. Ther. [Internet]. 2014 [cited 2015 Apr 22]; 9:82-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24359140 PMID: 24359140
33. Kai K, Nagano O, Sugihara E, Arima Y, Sampetrean O, Ishimoto T, et al. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci. [Internet]. 2009 [cited 2012 Nov 15]; 100:2275-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19737148 doi: 10.1111/j.1349-7006.2009.01318.x PMID: 19737148
34. Fan F, Bellister S, Lu J, Ye X, Boulbes DR, Tozzi F, et al. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells. Br. J. Cancer [Internet]. 2014; 112:539-46. Available from: http://www.nature.com/doifinder/10.1038/bjc.2014.620 doi: 10.1038/bjc.2014.620 PMID: 25535733
35. Calvet CY, André FM, Mir LM. The culture of cancer cell lines as tumorspheres does not systematically result in cancer stem cell enrichment. PLoS One [Internet]. 2014 [cited 2015 Jul 13]; 9:e89644. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3933663&tool= pmcentrez&rendertype=abstract doi: 10.1371/journal.pone.0089644 PMID: 24586931
36. Ahmad M, Frei K, Willscher E, Stefanski A, Kaulich K, Roth P, et al. How Stemlike Are Sphere Cultures From Long-term Cancer Cell Lines ? Lessons From Mouse Glioma Models. 2014; 73:1062-77.
37. Williams S a, Anderson WC, Santaguida MT, Dylla SJ. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab. Invest. [Internet]. Nature Publishing Group; 2013; 93:970-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23917877 doi: 10.1038/labinvest.2013.92 PMID: 23917877
38. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods [Internet]. 2009; 347:70-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19567251 doi: 10.1016/j.jim.2009.06.008 PMID: 19567251
39. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. [Internet]. 2002; 3:RESEARCH0034. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=126239&tool=pmcentrez&rendertype=abstract PMID: 12184808
40. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. [Internet]. 2007 [cited 2014 Jul 9]; 8:R19. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1852402&tool=pmcentrez&rendertype=abstract PMID: 17291332
41. Goswami CP, Nakshatri H. PROGgene: gene expression based survival analysis web application for multiple cancers. J. Clin. Bioinforma. [Internet]. Journal of Clinical Bioinformatics; 2013; 3:22. Available from: http://www.jclinbioinformatics.com/content/3/1/22 doi: 10.1186/2043-9113-3-22 PMID: 24165311
42. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010; 138:958-68. doi: 10.1053/j.gastro.2009.11.005 PMID: 19914252
43. Chen DT, Hernandez JM, Shibata D, Mccarthy SM, Humphries LA, Clark W, et al. Complementary strand microRNAs mediate acquisition of metastatic potential in colonic adenocarcinoma. J. Gastrointest. Surg. 2012; 16:905-13. doi: 10.1007/s11605-011-1815-0 PMID: 22362069
44. Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. [Internet]. 2013 [cited 2013 Nov 9]; 10:e1001453. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3660251&tool=pmcentrez&rendertype=abstract doi: 10.1371/journal.pmed. 1001453 PMID: 23700391
45. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann. Surg. Oncol. 2008; 15:638-48. PMID: 17932721
46. Shmelkov S V, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J. Clin. Invest. [Internet]. 2008 [cited 2015 Jul 11]; 118:2111-20. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2391278&tool=pmcentrez&rendertype=abstract doi: 10.1172/JCI34401 PMID: 18497886
47. Dangles-Marie V, Pocard M, Richon S, Weiswald L-B, Assayag F, Saulnier P, et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res. [Internet]. 2007 [cited 2012 Nov 6]; 67:398-407. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17210723 PMID: 17210723
48. Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell [Internet]. 2011 [cited 2012 Nov 8]; 9:357-65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21982235 doi: 10.1016/j.stem. 2011.08.010 PMID: 21982235
49. Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by. Cell Prolif. 2008; 41:51-6. doi: 10.1111/j.1365-2184.2008.00493.x PMID: 18181945
50. Liu A, Yu X, Liu S. Pluripotency transcription factors and cancer stem cells: Small genes make a big difference. Chin. J. Cancer. 2013; 32:483-7. doi: 10.5732/cjc.012.10282 PMID: 23419197
51. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. [Internet]. BioMed Central Ltd; 2012; 10:29. Available from: http://www.biomedcentral.com/1741-7007/10/29 doi: 10.1186/1741-7007-10-29 PMID: 22439642
52. Ye F-G, Song C-G, Cao Z-G, Xia C, Chen D-N, Chen L, et al. Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer. Cancer Res. [Internet]. 2015 [cited 2015 Apr 29]; 75:1504-15. Available from: http://cancerres.aacrjournals.org/content/75/7/1504.long doi: 10.1158/0008-5472.CAN-14-2341 PMID: 25643696
53. Weizman N, Krelin Y, Shabtay-Orbach A, Amit M, Binenbaum Y, Wong RJ, et al. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase. Oncogene [Internet]. 2014 [cited 2015 Feb 13]; 33:3812-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23995783 doi: 10.1038/onc.2013.357 PMID: 23995783
54. Kalinina E V, Berozov TT, Shtil AA, Chernov NN, Glasunova VA, Novichkova MD, et al. Expression of Genes of Glutathione Transferase Isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in Tumor Cells during the Formation of Drug Resistance to Cisplatin. 2012; 154:64-7. PMID: 23330092
55. Miranda-Lorenzo Irene; Dorado Jorge; Lonardo Enza; Alcala Sonia; Serrano Alicia G.; Clausell-Tormos Jenifer; Cioffi Michele; Megias Diego; Zagorac Sladjana; Balic Anamaria; Hidalgo Manuel; Erkan Mert; Kleeff Joerg; Scarpa Aldo; Sainz Br C Jr.. Intracellular auto-fluorescence-A novel and universally inherited biomarker in epithelial cancer stem cells. Nat. Methods. 2014; 11.
56. Sgambato a, Puglisi M a, Errico F, Rafanelli F, Boninsegna a, Rettino a, et al. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection. J. Cell. Physiol. [Internet]. 2010 [cited 2012 Nov 19]; 224:234-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20333645 doi: 10.1002/jcp.22124 PMID: 20333645
57. Kemper K, Grandela C, Medema JP. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget [Internet]. 2010 [cited 2015 May 29]; 1:387-95. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3248116&tool=pmcentrez&rendertype=abstract PMID: 21311095
58. Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC, et al. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell [Internet]. Elsevier Inc.; 2012; 21:11-24. Available from: http://dx.doi.org/10.1016/j.ccr.2011.11.025 doi: 10.1016/j.ccr. 2011.11.025 PMID: 22264785
59. O'Brien C a, Kreso A, Ryan P, Hermans KG, Gibson L, Wang Y, et al. ID1 and ID3 regulate the selfrenewal capacity of human colon cancer-initiating cells through p21. Cancer Cell [Internet]. Elsevier Inc.; 2012 [cited 2013 Feb 28]; 21:777-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22698403 doi: 10.1016/j.ccr.2012.04.036 PMID: 22698403
60. Kai K, Nagano O, Sugihara E, Arima Y, Sampetrean O, Ishimoto T, et al. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci. [Internet]. 2009 [cited 2012 Mar 8]; 100:2275-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19737148 doi: 10.1111/j.1349-7006.2009.01318.x PMID: 19737148
61. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature [Internet]. 2011 [cited 2012 Oct 25]; 474:318-26. Available from: http://www.ncbi.nlm. nih.gov/pubmed/21677748 doi: 10.1038/nature10212 PMID: 21677748
62. Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012; 13:679-87. doi: 10.1016/S1470-2045(12)70187-0 PMID: 22627104
63. García-González X, Cortejoso L, García MI, García-Alfonso P, Robles L, Grávalos C, et al. Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget [Internet]. 2015 [cited 2015 Apr 29]; 6:6422-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25691056 PMID: 25691056
64. Han M, Choong TL, Hong WZ, Chao S, Zheng R, Kok TY, et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin. Cancer Res. 2008; 14:455-60. doi: 10.1158/1078-0432.CCR-07-1801 PMID: 18203981
65. Kalinina E V, Chernov NN, Saprin AN, Kotova YN, Remizov VI, Shcherbak NP. Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance. Bull. Exp. Biol. Med. [Internet]. 2007 [cited 2015 Aug 6]; 143:328-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18225754 PMID: 18225754
66. He NG, Singhal SS, Srivastava SK, Zimniak P, Awasthi YC, Awasthi S. Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells. Arch. Biochem. Biophys. [Internet]. 1996 [cited 2015 Aug 6]; 333:214-20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8806773 PMID: 8806773
67. Ohata H, Ishiguro T, Aihara Y, Sato A, Sakai H, Sekine S, et al. Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells. Cancer Res. [Internet]. 2012 [cited 2012 Nov 8]; 72:5101-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23002207 doi: 10.1158/0008-5472.CAN-11-3812 PMID: 23002207
68. Zhao R, Quaroni L, Casson AG. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines. J. Thorac. Cardiovasc. Surg. [Internet]. 2012 [cited 2015 Nov 18]; 144:1192-9. Available from: http://www.sciencedirect.com/science/article/pii/S0022522312009567 doi: 10.1016/j.jtcvs.2012.08.008 PMID: 22980068
69. Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas. Oncogene [Internet]. 2012 [cited 2012 Nov 19]; 31:3901-12. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3426851&tool=pmcentrez&rendertype=abstract doi: 10.1038/onc.2011.541 PMID: 22139084
70. Zhang G, Ma L, Xie Y-K, Miao X-B, Jin C. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity. Mol. Med. Rep. [Internet]. 2012 [cited 2015 Nov 18]; 6:519-24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22684859 doi: 10.3892/mmr.2012.939 PMID: 22684859
71. Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. [Internet]. 2012 [cited 2015 Nov 18]; 323:161-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22521544 doi: 10.1016/j.canlet. 2012.04.004 PMID: 22521544
72. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens. Cell Stem Cell [Internet]. Elsevier Ltd; 2009; 4:568-80. Available from: http://dx.doi.org/10.1016/j.stem.2009.03.014 doi: 10.1016/j.stem.2009.03.014 PMID: 19497285
73. Hirsch D, Barker N, Mcneil N, Hu Y, Camps J, Mckinnon K, et al. LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis. 2014; 35:849-58. doi: 10.1093/carcin/bgt377 PMID: 24282287
74. Barker N, Ridgway R a, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature [Internet]. 2009 [cited 2012 Oct 25]; 457:608-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092804 doi: 10.1038/nature07602 PMID: 19092804
75. Walker F, Zhang H-H, Odorizzi A, Burgess AW. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS One [Internet]. 2011 [cited 2015 Jul 21]; 6:e22733. Available from: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=3145754&tool=pmcentrez&rendertype=abstract doi: 10.1371/journal.pone.0022733 PMID: 21829496